Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,045.83
4,136.43
3,977.49
3,757.57
3,447.09
3,236.37
3,618.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,045.83
4,136.43
3,977.49
3,757.57
3,447.09
3,236.37
3,618.90
Raw Material Cost
2,104.76
2,162.09
2,048.32
1,857.10
1,629.55
1,354.75
1,329.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.29
9.73
9.88
7.75
6.71
7.68
12.40
Selling and Distribution Expenses
783.35
883.34
959.15
933.22
948.07
1,139.65
1,560.24
Other Expenses
33.32
34.39
36.19
31.91
28.26
20.82
21.67
Total Expenditure (Excl Depreciation)
3,227.63
3,399.08
3,379.26
3,117.20
2,866.98
2,710.28
3,119.08
Operating Profit (PBDIT) excl Other Income
818.1999999999999
737.4
598.2
640.4000000000001
580.1
526.1
499.79999999999995
Other Income
106.13
182.21
118.96
132.97
143.33
126.50
131.21
Operating Profit (PBDIT)
1,166.71
1,205.33
919.61
951.29
893.92
795.91
726.37
Interest
6.29
9.73
9.88
7.75
6.71
7.68
12.40
Exceptional Items
-4.37
-40.19
25.82
10.89
-0.90
131.41
-0.10
Gross Profit (PBDT)
1,941.06
1,974.34
1,929.18
1,900.47
1,817.54
1,881.62
2,289.17
Depreciation
291.25
310.77
221.47
199.95
182.53
154.42
115.31
Profit Before Tax
864.80
844.64
714.08
754.48
703.79
765.21
598.56
Tax
97.66
124.85
84.62
82.49
81.57
105.65
81.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
757.98
711.96
618.90
662.25
612.54
653.07
520.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
757.98
711.96
618.90
662.25
612.54
653.07
520.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
8.69
7.16
4.52
5.57
5.42
0.26
1.55
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
766.67
719.13
623.42
667.82
617.96
653.33
521.95
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,833.04
5,969.51
5,512.37
5,146.12
4,861.54
3,917.60
3,696.08
Earnings per share (EPS)
0.92
0.83
0.72
0.77
0.75
0.83
0.64
Diluted Earnings per share
0.92
0.83
0.72
0.77
0.75
0.83
0.64
Operating Profit Margin (Excl OI)
19.02%
17.22%
14.56%
16.46%
16.48%
15.91%
13.26%
Gross Profit Margin
28.57%
27.93%
23.52%
25.4%
25.71%
28.42%
19.73%
PAT Margin
18.73%
17.21%
15.56%
17.62%
17.77%
20.18%
14.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -2.19% vs 3.99% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 6.62% vs 15.35% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 3.67% vs 27.78% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -35.05% vs -2.02% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Zhejiang Jingxin Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
4,045.83
0
4,045.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,045.83
0
4,045.83
Raw Material Cost
2,104.76
0
2,104.76
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.29
0
6.29
Selling and Distribution Expenses
783.35
0
783.35
Other Expenses
33.32
0.00
33.32
Total Expenditure (Excl Depreciation)
3,227.63
0
3,227.63
Operating Profit (PBDIT) excl Other Income
818.19
0.00
818.19
Other Income
106.13
0
106.13
Operating Profit (PBDIT)
1,166.71
0
1,166.71
Interest
6.29
0
6.29
Exceptional Items
-4.37
0
-4.37
Gross Profit (PBDT)
1,941.06
0
1,941.06
Depreciation
291.25
0
291.25
Profit Before Tax
864.80
0
864.80
Tax
97.66
0
97.66
Provisions and contingencies
0
0
0.00
Profit After Tax
757.98
0
757.98
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
757.98
0
757.98
Share in Profit of Associates
0
0
0.00
Minority Interest
8.69
0
8.69
Other related items
0.00
0.00
0.00
Consolidated Net Profit
766.67
0
766.67
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,833.04
0
5,833.04
Earnings per share (EPS)
0.92
0
0.92
Diluted Earnings per share
0.92
0
0.92
Operating Profit Margin (Excl OI)
19.02%
0%
0.00
19.02%
Gross Profit Margin
28.57%
0%
0.00
28.57%
PAT Margin
18.73%
0%
0.00
18.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 404.58 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -2.19% vs 3.99% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 76.67 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 6.62% vs 15.35% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 106.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 3.67% vs 27.78% in Dec 2024
Annual - Interest
Interest 0.63 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -35.05% vs -2.02% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.02%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






